Find your next paid study

Tessera Therapeutics, Inc.NCT07227207

Phase 1

A Phase 1b Study Evaluating Combinations With PSCA-Targeting Chimeric Antigen Receptor (CAR)-T Cells for Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer

This phase Ib trial tests the safety, side effects, and best dose of autologous anti-prostate stem cell antigen (PSCA)-chimeric antigen receptor (CAR)-4-1BB/TC…

Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8

City of Hope Medical CenterNCT05805371

Controller Development to Enable Individualized Assistance in Robotic Ankle Exoskeletons

This study is developing and testing a new controller for a robotic ankle exoskeleton (Biomotum) that can adjust itself in real time to better support people w…

Healthy Young Adults

University of NebraskaNCT07393971

Phase 2

A Randomized, Multicenter, Double-Blind, Parallel, Placebo-controlled Phase 2b Clinical Trial to Evaluate the Efficacy and Safety of YN001 in Adults With Coronary Atherosclerosis

This study is designed to evaluate the efficacy and safety of intravenously administered YN001 in patients diagnosed with coronary atherosclerosis, who are rec…

AtherosclerosisCoronary Artery Disease

Beijing Inno Medicine Co., Ltd.NCT07521007

Phase 1

A Phase 1, Multicenter, Open-label, Non-randomized, Dose-escalation and Backfill Study of KK2223 in Participants With Relapsed or Refractory T-cell Non Hodgkin Lymphoma

The purpose of this study is to determine the safety, tolerability, PK and pharmacodynamics of KK2223 in adult participants with relapsed or refractory periphe…

T-cell NHL (PTCL or CTCL)

Kyowa Kirin, Inc.NCT07192471

Phase 3

A Phase 3 Randomized Open-Label Study of Adjuvant Pembrolizumab With or Without MK-2870 in Participants With Resectable Stage II to IIIB (N2) NSCLC Not Achieving pCR After Receiving Neoadjuvant Pembrolizumab With Platinum-based Doublet Chemotherapy Followed by Surgery

This study will assess if adding sacituzumab tirumotecan with pembrolizumab after surgery is effective in treating NSCLC for participants not achieving patholo…

Non Small Cell Lung Cancer

Merck Sharp & Dohme LLCNCT06312137

Phase 1

BRIDGE - Blocking Receptor of IL-1β for Donor Graft Edema Reduction

This study will determine if primary graft dysfunction (which causes low blood oxygen levels and fluid or inflammation in the lungs) after lung transplant can …

Lung Transplant Recipient

Northwestern UniversityNCT07410312

Phase 2

Pharmacokinetics and Pharmacodynamics of Oxytocin in Cesarean Delivery

Oxytocin is the first-line drug to promote contraction of the uterus and prevent atony immediately after delivery. Nonetheless, unpredictable uterine atony ref…

Post Partum HemorrhageCesarean Section ComplicationsBlood Loss

Stanford UniversityNCT05488457

Anastomotic LeaksHartmanns Stump Leakage

A Prospective Multicenter Trial Evaluating the Safety and Effectiveness of Endo-SPONGE for the Treatment of Anastomotic or Hartmann's Stump Leakages in the Lower Pelvic Area

This study is intended to evaluate the safety and effectiveness of Sponge-based Endoscopic Vacuum Therapy (EVT) using Endo-SPONGE for the treatment of Anastomo…

Boston Scientific CorporationNCT07035431

Healthy VolunteersVirtual Reality

Cybersickness Prevention and Mitigation in Virtual Reality for Healthy Volunteers

Background: People use virtual reality (VR) technology to play games, socialize, work, or receive medical care. Some people have "cybersickness" after using V…

National Human Genome Research Institute (NHGRI)NCT06552754

~$10 – $5,625

Social Behavior DisordersNeurodevelopmental Disorders

The Effects of the Melillo Method® on Biopsychosocial Outcomes in School-Age Children: A Pilot Randomized Delayed-Start Trial

This pilot study will test whether a school-based neurodevelopmental brain-training program, called the Melillo Method®, is feasible to deliver and study in el…

Life UniversityNCT07779889

Phase 3

A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants With Elevated Lipoprotein(a)

The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardial infarct…

Cardiovascular Disease